ArticleLeukemia & lymphoma2012

Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia.

Clive S Zent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.